​

Assembly Biosciences (ASMB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ASMB Stock Forecast

Assembly Biosciences (ASMB) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $35.50, with a high of $36.00 and a low of $35.00. This represents a 108.21% increase from the last price of $17.05.

- $8 $16 $24 $32 $40 High: $36 Avg: $35.5 Low: $35 Last Closed Price: $17.05

ASMB Stock Rating

Assembly Biosciences stock's rating consensus is Hold, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (40.00%), 6 Hold (60.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 10 0 6 4 Strong Sell Sell Hold Buy Strong Buy

ASMB Price Target Upside V Benchmarks

TypeNameUpside
StockAssembly Biosciences108.21%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$35.50
Last Closing Price$17.05$17.05$17.05
Upside/Downside--108.21%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-2---2
May, 25-21--3
Apr, 25-31--4
Mar, 25-21--3
Feb, 25-21--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Salim SyedMizuho Securities$36.00$16.26121.40%111.14%
Sep 20, 2024Dennis DingJefferies$35.00$18.5089.19%105.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 25, 2025GuggenheimBuyinitialise
Sep 24, 2024H.C. WainwrightNeutralNeutralhold
Sep 20, 2024JefferiesBuyupgrade

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.50$-2.79$-13.38$-6.69----
Avg Forecast$-18.67$-25.20$-14.22$-6.76$-7.37$-6.24$-9.74$-8.01
High Forecast$-15.07$-20.34$-13.75$-6.53$-6.99$-5.91$-9.41$-7.74
Low Forecast$-21.27$-28.70$-14.69$-6.98$-7.74$-6.56$-10.06$-8.28
Surprise %-91.97%-88.93%-5.91%-1.04%----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$79.11M$6.25M$7.16M-----
Avg Forecast$82.01M$7.41M$7.16M$24.60M$32.65M$105.00M$221.00M$299.00M
High Forecast$90.78M$8.21M$7.35M$25.23M$33.49M$107.69M$226.67M$306.67M
Low Forecast$69.85M$6.31M$6.98M$23.97M$31.81M$102.31M$215.33M$291.33M
Surprise %-3.54%-15.63%------

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-59.53M$-129.85M$-61.23M$-40.18M----
Avg Forecast$-20.57M$-115.35M$-65.09M$-30.92M$-33.71M$-28.54M$-44.56M$-36.66M
High Forecast$5.35M$-93.11M$-62.92M$-29.89M$-32.02M$-27.05M$-43.07M$-35.44M
Low Forecast$-46.49M$-131.39M$-67.26M$-31.95M$-35.41M$-30.03M$-46.05M$-37.89M
Surprise %189.39%12.57%-5.93%29.94%----

ASMB Forecast FAQ

Is Assembly Biosciences stock a buy?

Assembly Biosciences stock has a consensus rating of Hold, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Assembly Biosciences is a neutral investment for most analysts.

What is Assembly Biosciences's price target?

Assembly Biosciences's price target, set by 10 Wall Street analysts, averages $35.5 over the next 12 months. The price target range spans from $35 at the low end to $36 at the high end, suggesting a potential 108.21% change from the previous closing price of $17.05.

How does Assembly Biosciences stock forecast compare to its benchmarks?

Assembly Biosciences's stock forecast shows a 108.21% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Assembly Biosciences over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Assembly Biosciences’s EPS forecast?

Assembly Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-7.37, marking a 10.16% increase from the reported $-6.69 in 2024. Estimates for the following years are $-6.24 in 2026, $-9.74 in 2027, and $-8.01 in 2028.

What is Assembly Biosciences’s revenue forecast?

Assembly Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $32.65M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $105M, followed by $221M for 2027, and $299M for 2028.

What is Assembly Biosciences’s net income forecast?

Assembly Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-33.713M, representing a -16.09% decrease from the reported $-40.177M in 2024. Projections indicate $-28.54M in 2026, $-44.561M in 2027, and $-36.665M in 2028.